GENFIT (EPA:GNFT) | Finanzwire

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
GENFIT

BRIEF

published on 11/07/2024 at 22:15, 1 month 13 days ago

GENFIT Reports Third Quarter 2024 Financial Update

Revenue Growth PBC Treatment GENFIT Financials Cash Position 2024 Ipsen Collaboration
PRESS RELEASE

published on 11/07/2024 at 22:10, 1 month 13 days ago

GENFIT Reports Third Quarter 2024 Financial Information
GENFIT reports €59.7M revenue for Q3 2024 with €96.0M cash. Focus on liver diseases. Results surpass 2023

Revenue Cash Position Q3 2024 Liver Diseases GENFIT
PRESS RELEASE

published on 09/19/2024 at 22:10, 3 months 1 day ago

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
BRIEF

published on 07/26/2024 at 13:50, 4 months 26 days ago

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® in Primary Biliary Cholangitis

GENFIT EMA Iqirvo® Elafibranor PBC Treatment
PRESS RELEASE

published on 07/26/2024 at 13:45, 4 months 26 days ago

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
GENFIT receives positive opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis, awaiting final European Commission decision. Details in press release

GENFIT PBC Treatment Positive Opinion EMA Committee Ipsen's Iqirvo
BRIEF

published on 07/09/2024 at 22:15, 5 months 11 days ago

GENFIT Announces Half-Year Liquidity Contract Report with Crédit Industriel et Commercial

Liquidity Contract Shares Biopharmaceutical GENFIT Trading Report
PRESS RELEASE

published on 07/09/2024 at 22:10, 5 months 11 days ago

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, revealing trading details and resources as of June 30, 2024

Liquidity Contract Crédit Industriel Et Commercial GENFIT Resources Trading Details
BRIEF

published on 06/17/2024 at 22:15, 6 months 3 days ago

GENFIT: NIS2+® Included in New Clinical Guidelines for MASLD

GENFIT MASH NIS2+® MASLD Clinical Guidelines
PRESS RELEASE

published on 06/17/2024 at 22:10, 6 months 3 days ago

GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
GENFIT announces inclusion of NIS2+® in new EASL-EASD-EASO Clinical Practice Guidelines for MASLD, as a key tool for detecting at-risk MASH. Guidelines provide update on prevention, screening, diagnosis, follow-up, and treatment for MASLD

GENFIT MASH NIS2+® MASLD EASL-EASD-EASO
BRIEF

published on 06/10/2024 at 23:27, 6 months 10 days ago

GENFIT: Accelerated approval of Iqirvo® by the FDA for Primary Biliary Cholangitis

FDA Biopharmaceutical Primary Biliary Cholangitis GENFIT Iqirvo

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 50 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 50 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 15 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 20 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 50 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 28 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 34 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 2 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE